# Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

> **NCT00239460** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 196 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Tiotropium

## Key facts

- **NCT ID:** NCT00239460
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-03
- **Final completion:** —
- **Target enrollment:** 196 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239460, "Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00239460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*